Charles Pauling Semba
CIK: 0001872863
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
DiaMedica Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 1, 2026DMAC
DiaMedica Therapeutics Inc.
Award(A)DirectStock Option (right to buy)
40.4K shares- - Jan 2, 2026DMAC
DiaMedica Therapeutics Inc.
Award(A)Direct3.4K shares at avg. $8.42$28K - Jun 1, 2025DMAC
DiaMedica Therapeutics Inc.
Award(A)DirectStock Option (right to buy)
32.2K shares- - Jan 2, 2025DMAC
DiaMedica Therapeutics Inc.
Award(A)Direct5.3K shares at avg. $5.34$28K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 1, 2026 | DMAC DiaMedica Therapeutics Inc. | Award(A) Stock Option (right to buy) | 40,412 | - | - | Direct |
| Jan 2, 2026 | DMAC DiaMedica Therapeutics Inc. | Award(A) | 3,355 | $8.42 | $28,249 | Direct |
| Jun 1, 2025 | DMAC DiaMedica Therapeutics Inc. | Award(A) Stock Option (right to buy) | 32,162 | - | - | Direct |
| Jan 2, 2025 | DMAC DiaMedica Therapeutics Inc. | Award(A) | 5,290 | $5.34 | $28,249 | Direct |
1-4 of 4 transactions
About Semba Charles Pauling
Semba Charles Pauling (SEC CIK 0001872863) files insider reports with the SEC as Director of DiaMedica Therapeutics Inc. (DMAC).
Signal8 holds 4 ownership filings by Semba Charles Pauling, all Form 4s, filed between Jan 3, 2025 and Jun 3, 2026. Those filings report 4 transactions, from Jan 2, 2025 to Jun 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Semba Charles Pauling's filings is in MINNEAPOLIS, MN.
Recent filings by Semba Charles Pauling
Other insiders filing for DiaMedica Therapeutics Inc. (DMAC)
- Pauls Dietrich John, President & CEO
- Giuffre Randall Michael, Director
- Kuntz Richard, Director
- O'Connor Daniel J., Director
- Lewis Tanya, Director
- Parsons James T., Director